This is a routine board compensation event with negligible dilution (5,300 shares vs. outstanding float). No trading catalyst, monitor upcoming earnings or pipeline updates for material moves.
Price Chart
Executive Summary
Genmab held an Extraordinary General Meeting on October 7, 2026, where shareholders approved the Board's 2026 remuneration proposal, including the grant of 5,300 restricted stock units (RSUs) to board members. Each RSU has a fair value of DKK 2,487.00 and vests after three years. This is a routine governance and compensation matter with no material financial or operational impact.
Key Facts
- Extraordinary General Meeting held October 7, 2026
- Approved Board remuneration for 2026, including share-based compensation
- 5,300 restricted stock units granted to board members
- Each RSU fair value: DKK 2,487.00 (closing price on grant date)
- RSUs vest after three years from grant date
Financial Impact
Total fair value of RSUs granted: 5,300 × DKK 2,487 = approximately DKK 13.2 million (~$1.9 million at current exchange rates). Immaterial relative to Genmab's market cap.
Risk Factors
- No material risks identified from this filing
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001434265-26-000134 |
| Document: gmab_20261007x6k.htm | 0001434265-26-000134 |
| Document: 0001434265-26-000134-index-headers.html | 0001434265-26-000134 |
| Document: 0001434265-26-000134-index.html | 0001434265-26-000134 |
| Document: 0001434265-26-000134.txt | 0001434265-26-000134 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 28, 2026 1d ago | 6-K | $50.77 | awaiting T+1 | awaiting T+1 | $56.11 (+10.52%) |
Oct 23, 2026 6d ago | 6-K | $43.79 $44.69 | ▲ +2.04% | ▲ +1.33% | $56.11 (+28.13%) |
Oct 13, 2026 16d ago | 6-K | $36.57 $36.89 | ▲ +0.88% | ▲ +1.96% | $56.11 (+53.43%) |
Oct 7, 2026 22d ago | 6-K | $36.65 $36.05 | ▼ −1.64% | ▼ −1.21% | $56.11 (+53.10%) |
Oct 5, 2026 23d ago | SC 13G | $37.80 $36.65 | ▼ −3.04% | ▼ −2.80% | $56.11 (+48.44%) |
Oct 5, 2026 23d ago | 6-K | $38.48 $37.80 | ▼ −1.77% | ▼ −2.32% | $56.11 (+45.82%) |
Oct 2, 2026 26d ago | 6-K | $34.75 $38.48 | ▲ +10.73% | ▲ +10.06% | $56.11 (+61.47%) |
Sep 29, 2026 4w ago | 6-K | $35.57 $35.68 | ▲ +0.30% | ▲ +0.50% | $56.11 (+57.75%) |
Sep 24, 2026 4w ago | 6-K | $34.83 $35.32 | ▲ +1.41% | ▲ +0.86% | $56.11 (+61.10%) |
Sep 8, 2026 7w ago | 6-K | $33.53 $33.04 | ▼ −1.46% | ▼ −1.00% | $56.11 (+67.34%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers